Featured Research

from universities, journals, and other organizations

Breast Cancer Gene Can Be Blocked By Blood Pressure Drug

Date:
June 7, 2009
Source:
University of Michigan Health System
Summary:
Researchers have identified a gene that is overexpressed in up to 20 percent of breast cancers and that could be blocked in the lab by a currently available blood pressure drug, according to a new study.

Researchers Arul Chinnaiyan and Scott Tomlins. Researchers have identified a gene that is overexpressed in up to 20 percent of breast cancers and that could be blocked in the lab by a currently available blood pressure drug.
Credit: University of Michigan Health System

Researchers have identified a gene that is overexpressed in up to 20 percent of breast cancers and that could be blocked in the lab by a currently available blood pressure drug, according to a new study from the University of Michigan Comprehensive Cancer Center.

Related Articles


The gene, called AGTR1, caused normal breast cells to behave like cancer cells. This behavior was reversed by treatment with the blood pressure drug losartan. Tumors in mice that expressed AGTR1 shrunk by 30 percent eight weeks after treatment with losartan, a drug approved by the U.S. Food and Drug Administration to treat high blood pressure.

"We suspect our analysis has uncovered a new crop of potentially important breast cancer genes. What's also exciting is this gene is blocked by a drug that's already available on the market," says study author Arul Chinnaiyan, M.D., Ph.D., director of the Michigan Center for Translational Pathology and S.P. Hicks Endowed Professor of Pathology at the U-M Medical School.

Results of the study appear online the week of June 1 in the Proceedings of the National Academy of Sciences.

The researchers looked at gene expression profiling data from nearly 3,200 microarrays available in the Oncomine database, a tool that allows rapid comparison of thousands of genes in human cancers. The researchers found genes that were dramatically overexpressed within subsets of tumors.

The gene that came up most often was ERBB2, which is better known as HER2, a gene that is overexpressed in 25 percent to 30 percent of all human breast cancers. HER2 is blocked by the targeted therapy Herceptin.

The next most commonly seen gene behind ERBB2 was AGTR1, which was seen in 10 percent to 20 percent of breast tumors. Specifically, AGTR1 was overexpressed only in tumors that were ERBB2-negative and that expressed the estrogen receptor, known as ER-positive. AGTR1 was found to be as much as 100-fold overexpressed in some tumors.

"AGTR1 is very analogous to HER2 or ERBB2. HER2 is a bona fide treatment target for patients with that type of breast cancer. This research defines a novel subtype of ER-positive breast cancer that we hope can be similarly targeted for treatment," says Chinnaiyan, a Howard Hughes Medical Institute investigator.

The researchers tested in cell cultures and in mice the effect of losartan on AGTR1-positive tumors. When losartan was introduced, the AGTR1-positive tumors were reduced, while AGTR1-negative tumors were not affected. In the mice studies, losartan shrank AGTR1-positive tumors by 20 percent after two weeks and by 30 percent after eight weeks.

"Losartan may be a viable therapy for women with AGTR1 over-expressing breast tumors. This study lays the groundwork for a clinical trial to test losartan to treat breast cancers positive for AGTR1," Chinnaiyan says.

Researchers are discussing a possible clinical trial, but one is not currently designed or recruiting for participants.

Additional authors include Daniel R. Rhodes, Bushra Ateeq, Qi Cao, Scott A. Tomlins, Rohit Mehra, Bharathi Laxman, Shanker Kalyana-Sundaram, Robert J. Lonigro, Beth E. Helgeson, Mahaveer S. Bhojani, Alnawaz Rehemtulla, Celina G. Kleer, Daniel F. Hayes, Peter C. Lucas and Sooryanarayana Varambally.

Funding was provided by the Department of Defense Era of Hope Scholar Award, Early Detection Research Network Biomarker Devleopmental Lab, Department of Defense, U-M Cancer Center Bioinformatics Core, Rackham Predoctoral Fellowship, Clinical Translational Research Award from the Burroughs Welcome Foundation and Doris Duke Charitable Foundation Distinguished Clinical Scientist Award. Losartan was provided by Merck U.S.A.

The University of Michigan has filed a patent on AGTR1 and is currently seeking a commercial partner to help bring this technology to market.

Breast cancer statistics: 194,280 Americans will be diagnosed with breast cancer this year and 40,610 will die from the disease, according to the American Cancer Society.


Story Source:

The above story is based on materials provided by University of Michigan Health System. Note: Materials may be edited for content and length.


Cite This Page:

University of Michigan Health System. "Breast Cancer Gene Can Be Blocked By Blood Pressure Drug." ScienceDaily. ScienceDaily, 7 June 2009. <www.sciencedaily.com/releases/2009/06/090601182651.htm>.
University of Michigan Health System. (2009, June 7). Breast Cancer Gene Can Be Blocked By Blood Pressure Drug. ScienceDaily. Retrieved December 20, 2014 from www.sciencedaily.com/releases/2009/06/090601182651.htm
University of Michigan Health System. "Breast Cancer Gene Can Be Blocked By Blood Pressure Drug." ScienceDaily. www.sciencedaily.com/releases/2009/06/090601182651.htm (accessed December 20, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, December 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Best Tips to Curb Holiday Carbs

The Best Tips to Curb Holiday Carbs

Buzz60 (Dec. 19, 2014) It's hard to resist those delicious but fattening carbs we all crave during the winter months, but there are some ways to stay satisfied without consuming the extra calories. Vanessa Freeman (@VanessaFreeTV) has the details. Video provided by Buzz60
Powered by NewsLook.com
Sierra Leone Bikers Spread the Message to Fight Ebola

Sierra Leone Bikers Spread the Message to Fight Ebola

AFP (Dec. 19, 2014) More than 100 motorcyclists hit the road to spread awareness messages about Ebola. Nearly 7,000 people have now died from the virus, almost all of them in west Africa, according to the World Health Organization. Video provided by AFP
Powered by NewsLook.com
Researchers Test Colombian Village With High Alzheimer's Rates

Researchers Test Colombian Village With High Alzheimer's Rates

AFP (Dec. 19, 2014) In Yarumal, a village in N. Colombia, Alzheimer's has ravaged a disproportionately large number of families. A genetic "curse" that may pave the way for research on how to treat the disease that claims a new victim every four seconds. Duration: 02:42 Video provided by AFP
Powered by NewsLook.com
The Best Protein-Filled Foods to Energize You for the New Year

The Best Protein-Filled Foods to Energize You for the New Year

Buzz60 (Dec. 19, 2014) The new year is coming and nothing will energize you more for 2015 than protein-filled foods. Fitness and nutrition expert John Basedow (@JohnBasedow) gives his favorite high protein foods that will help you build muscle, lose fat and have endless energy. Video provided by Buzz60
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins